Diclofenac Sodium Gel
Product Images NDC 68071-3671

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 68071-3671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3671 1)

Diclofenac Sodium 1% topical gel, 3.53 oz (100 g), distributed by Perrigo Allegan, MI, and packaged by NuCare Pharmaceuticals, Inc., Orange, CA. The label includes active ingredient information, warnings, storage instructions, and lot and expiration details. It features a red NuCare Pharmaceuticals logo at the top.*

FDA Label Image

Image 1 (Image 01)

An instructional illustration showing a pair of hands opening a product carton and removing a single-use packet or sachet labeled with medication details. The depiction emphasizes the proper handling of a packaged topical gel product, likely diclofenac sodium 10 mg/g.*

FDA Label Image

Image 2 (Image 02)

Instructional diagram showing how to remove and replace the cap on a tube, open the safety seal by pressing the cap onto the seal or lifting the foil tab, and cautions against using scissors or sharp objects to open the safety seal. The illustrations include hands handling the tube and cap, with step-by-step labels.*

FDA Label Image

Image 3 (Image 03)

An instructional illustration showing four panels representing times of day: start of the day (sunrise), middle of the day (bright sun), late afternoon (sunset), and end of the day (crescent moon). This likely relates to timing for topical gel application instructions for diclofenac sodium 10 mg/g.*

FDA Label Image

Image 4 (Image 04)

An instructional diagram with four human figures illustrating correct and incorrect application areas for a topical product. It shows correct use on one or two areas such as hand and knee or both knees, and incorrect use on three areas including hands and ankles.*

FDA Label Image

Image 5 (Image 05)

An instructional illustration showing a hand squeezing a tube labeled "Perrigo Diclofenac Sodium" onto a dosing card. The dosing card is marked for a lower body dose measuring 4.5 inches long (4 grams). The image demonstrates the use of the dosing card to measure topical gel application.*

FDA Label Image

Image 6 (Image 06)

Illustration of a dosing card for diclofenac sodium topical gel 1%. The diagram shows the correct amount of gel to apply for upper body dosing, specifying 2.35 inches (2 grams) to guide patients in measuring the proper dose from the tube.*

FDA Label Image

Image 7 (Image 07)

An instructional diagram illustrating the application areas for a topical gel on the upper and lower body. It shows hand illustrations applying gel to the elbow, wrist, and hand on the upper body, and to the knee, ankle, and foot on the lower body, specifying the inclusion of sides, inner/outer parts, and specific regions like the kneecap, palm, sole, and toes.*

FDA Label Image

Image 8 (Image 08)

An instructional illustration showing hands being rinsed under running water from a faucet. The image depicts water flowing onto one hand, suggesting the action of washing or rinsing.*

FDA Label Image

Image 9 (Image 09)

Illustration showing hands holding a tube of topical gel under running water from a faucet. The image likely demonstrates rinsing the cap or tube opening of the diclofenac sodium topical gel product.*

FDA Label Image

Image 10 (Image 10)

An illustration of a clock face highlighting a 10-minute interval, showing the text '10 minutes' inside the clock. The design visually represents a 10-minute duration.*

FDA Label Image

Image 11 (Image 11)

An anatomical illustration showing a comparison of knee joint cartilage. The left side depicts healthy cartilage with smooth, intact surfaces. The right side shows worn-away cartilage with visible broken sections, indicating cartilage damage or deterioration.*

FDA Label Image

Image 12 (Image 12)

An instructional diagram showing areas for topical application of diclofenac sodium gel. It highlights the upper body (hand and elbow), lower body (knee and ankle), upper/lower body (wrist and ankle), and specifies left (L) and right (R) knees for targeted application.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.